Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urinary Bladder Neoplasms × Immunoenzyme Techniques × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Lung Neoplasms 4 Breast Neoplasms 4 Breast Neoplasms, Male 3 Sarcoma 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Kidney Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Melanoma 1 Liver Neoplasms 1 Liposarcoma 1 Leukemia 1 Hepatitis C 1 Head and Neck Neoplasms 1 Gliosarcoma 1

Interventions

Gemcitabine 47 Cisplatin 32 pembrolizumab 28 Paclitaxel 13 Docetaxel 13 avelumab 12 Mitomycin 12 atezolizumab 11 Nivolumab 11 Cystectomy 9 Carboplatin 9 durvalumab 7 Sunitinib 7 apaziquone 6 Doxorubicin 6 BCG Vaccine 6 5-aminolevulinic acid hexyl ester 6 Vinblastine 5 Platinum 5 Methotrexate 5 Magnetic Resonance Spectroscopy 5 Albumin-Bound Paclitaxel 5 Taxes 4 Standard of Care 4 Sorafenib 4 Radiotherapy 4 Radiation 4 Fluorouracil 4 Erlotinib Hydrochloride 4 1,2-diaminocyclohexaneplatinum II citrate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡